Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

A scalable serology solution for profiling humoral immune responses to SARS-CoV-2 infection and vaccination
Karen Colwill, Yannick Galipeau, Matthew Stuible, et al.
medRxiv (Cold Spring Harbor Laboratory) (2021)
Closed Access | Times Cited: 10

Showing 10 citing articles:

Relative Ratios of Human Seasonal Coronavirus Antibodies Predict the Efficiency of Cross-Neutralization of SARS-CoV-2 Spike Binding to ACE2
Yannick Galipeau, Vinayakumar Siragam, Geneviève Laroche, et al.
EBioMedicine (2021) Vol. 74, pp. 103700-103700
Open Access | Times Cited: 50
Differences in mRNA-1273 (Moderna) and BNT162b2 (Pfizer-BioNTech) SARS-CoV-2 vaccine immunogenicity among patients undergoing dialysis
Kevin Yau, Christopher T. Chan, Kento T. Abe, et al.
Canadian Medical Association Journal (2022) Vol. 194, Iss. 8, pp. E297-E305
Open Access | Times Cited: 34
Assessment of SARS-CoV-2 Seropositivity During the First and Second Viral Waves in 2020 and 2021 Among Canadian Adults
Xuyang Tang, Abha Sharma, Maria Pasic, et al.
JAMA Network Open (2022) Vol. 5, Iss. 2, pp. e2146798-e2146798
Open Access | Times Cited: 28
Ku-gaa-gii pimitizi-win, the COVID-19 cohort study of people experiencing homelessness in Toronto, Canada: a study protocol
Lucie Richard, Rosane Nisenbaum, Michael Liu, et al.
BMJ Open (2022) Vol. 12, Iss. 8, pp. e063234-e063234
Open Access | Times Cited: 11
Accelerated waning of immunity to SARS-CoV-2 mRNA vaccines in patients with immune mediated inflammatory diseases
Roya Monica Dayam, Jaclyn C. Law, Rogier Goetgebuer, et al.
medRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 7
Safety and Efficacy of Preventative COVID Vaccines: The StopCoV Study
Sharon Walmsley, Leah Szadkowski, Bradly G. Wouters, et al.
medRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 5
SARS-CoV-2 Virus-Like Particle Neutralizing Capacity in Blood Donors Depends on Serological Profile and Donor-Declared SARS-CoV-2 Vaccination History
Steven J. Drews, Queenie Hu, Reuben Samson, et al.
Microbiology Spectrum (2022) Vol. 10, Iss. 1
Open Access | Times Cited: 5
What factors converged to create a COVID-19 hot-spot? Lessons from the South Asian community in Ontario
Sonia S. Anand, Corey Arnold, Shrikant I. Bangdiwala, et al.
medRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 5
Arsenal of Nanobodies for Broad-Spectrum Countermeasures against Current and Future SARS-CoV-2 Variants of Concerns
Martín A. Rossotti, Henk van Faassen, Anh Tran, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 2
Différences d’immunogénicité des vaccins anti-SRAS-CoV-2 mRNA-1273 (Moderna) et BNT162b2 (Pfizer-BioNTech) chez les patients dialysés
Kevin Yau, Christopher T. Chan, Kento T. Abe, et al.
Canadian Medical Association Journal (2022) Vol. 194, Iss. 21, pp. E751-E760
Open Access | Times Cited: 1
Page 1

Scroll to top